Research output per year
Research output per year
Personal profile
Fields of Science
- 3112 Neurosciences
- 1182 Biochemistry, cell and molecular biology
International and National Collaboration
Publications and projects within past five years.
-
A prolyl oligopeptidase inhibitor reduces tau pathology in cellular models and in mice with tauopathy
Eteläinen, T., Silva, M. C., Uhari-Väänänen, J., De Lorenzo, F., Jäntti, M., Cui, H., Chavero-Pieres, M., Kilpeläinen, T., Mechtler, C., Svarcbahs, R., Seppälä, E., Savinainen, J., Puris, E., Fricker, G., Gynther, M., Julku, U., Huttunen, H., Haggarty, S. & Myöhänen, T., 12 Apr 2023, In: Science translational medicine. 15, 691, 10.1126/scitranslmed.abq2915.Research output: Contribution to journal › Article › Scientific › peer-review
-
Augmenting hematoma-scavenging capacity of innate immune cells by CDNF reduces brain injury and promotes functional recovery after intracerebral hemorrhage
Tseng, K-Y., Stratoulias, V., Hu, W-F., Wu, J-S., Wang, V., Chen, Y-H., Seelbach, A., Huttunen, H. J., Kulesskaya, N., Pang, C-Y., Chou, J-L., Lindahl, M., Saarma, M., Huang, L-C., Airavaara, M. & Liew, H-K., 15 Feb 2023, In: Cell Death and Disease. 14, 2, 20 p., 128.Research output: Contribution to journal › Article › Scientific › peer-review
Open AccessFile -
Cerebral dopamine neurotrophic factor reduces α-synuclein aggregation and propagation and alleviates behavioral alterations in vivo
Albert, K., Raymundo, D. P., Panhelainen, A., Eesmaa, A., Shvachiy, L., Araujo, G. R., Chmielarz, P., Yan, X., Singh, A., Cordeiro, Y., Palhano, F. L., Foguel, D., Luk, K. C., Domanskyi, A., Voutilainen, M. H., Huttunen, H. J., Outeiro, T. F., Saarma, M., Almeida, M. S. & Airavaara, M., 1 Sep 2021, In: Molecular therapy. 29, 9, p. 2821-2840 20 p.Research output: Contribution to journal › Article › Scientific › peer-review
Open AccessFile -
Membrane interaction and disulphide-bridge formation in the unconventional secretion of Tau
Hellen, M., Bhattacharjee, A., Uronen, R-L. & Huttunen, H. J., Aug 2021, In: Bioscience Reports. 41, 8, 10 p., 20210148.Research output: Contribution to journal › Article › Scientific › peer-review
Open AccessFile -
Reduced evoked activity and cortical oscillations are correlated with anisometric amblyopia and impairment of visual acuity
Julku, H., Rouhinen, S., Huttunen, H., Lindberg, L., Liinamaa, J. M., Saarela, V., Karvonen, E., Booms, S., Mäkelä, J. P., Uusitalo, H., Castrén, E., Palva, M. & Palva, S., 15 Apr 2021, In: Scientific Reports. 11, 1, 15 p., 8310.Research output: Contribution to journal › Article › Scientific › peer-review
Open AccessFile
Prizes
-
Innovation prize of the Chemical Industry Federation of Finland
Huttunen, Henri (Recipient), 19 Apr 2018
Prize: Prizes and awards
-
Novartis Exelon Prize 2002: Best Ph.D. Thesis in Neuroscience in Finland in 2002, Brain Research Society of Finland & Novartis
Huttunen, Henri (Recipient), 23 Aug 2003
Prize: Prizes and awards
-
Viikki Biocenter Ph.D. Thesis Prize 2002: Best Ph.D. Thesis in Viikki Campus in 2002
Huttunen, Henri (Recipient), 2003
Prize: Prizes and awards
Activities
-
Red Eye Neurology Seminar
Henri Huttunen (Speaker: Presenter)
3 Oct 2019Activity: Participating in or organising an event types › Public Talks
-
From a Molecule to Business: The Story of One Molecule (So Far)
Henri Huttunen (Invited speaker)
22 Jan 2019Activity: Talk or presentation types › Oral presentation
-
A First-in-Human Clinical Study to Test Safety and Preliminary Efficacy of CDNF in Parkinson’s Disease
Henri Huttunen (Speaker)
28 Mar 2019Activity: Talk or presentation types › Oral presentation
-
Drug development in Alzheimer's disease
Henri Huttunen (Invited speaker)
14 May 2019Activity: Talk or presentation types › Oral presentation
-
Business Finland (External organisation)
Henri Huttunen (Expert member)
Jan 2019 → …Activity: Membership types › Membership or other role in national/international committee, council, board
Press/Media
-
Herantis Pharma Announces Paper in Journal Genes on biomarker -driven approaches in Parkinson's Disease
30/09/2021
2 items of Media coverage
Press/Media: Press / Media
-
Herantis Pharma Oyj: Herantis Pharma Announces Paper in Journal Genes on biomarker -driven approaches in Parkinson’s Disease (Cision)
30/09/2021
2 items of Media coverage
Press/Media: Press / Media
-
-Herantis Pharma Announces Poster and Presentation at MDS Virtual Congress 2021
20/09/2021
1 item of Media coverage
Press/Media: Press / Media
-
Herantis Pharma Announces Poster and Presentation at MDS Virtual Congress 2021
17/09/2021
3 items of Media coverage
Press/Media: Press / Media
-
Herantis Pharma Oyj: Herantis Pharma Announces Poster and Presentation at MDS Virtual Congress 2021 (Cision)
17/09/2021
1 item of Media coverage
Press/Media: Press / Media